Special Issue "Inflammation and the Musculoskeletal System"
Deadline for manuscript submissions: 28 February 2022.
Interests: cartilage; adipokines; bone; chondrocytes; osteoblasts; osteoarthritis; rheumatoid arthritis; TLR4; inflammation; heterotopic ossification
Inflammation and its associated consequences have shown a prominent role in the onset and progression of multiple diseases. Hence, multiple pharmacological approaches have been taken throughout human history to control inflammation and to improve human quality of life. Since the first commercialization of acetylsalicylic acid in 1899, huge advances have been achieved in the control of inflammation: corticoids, multiple nonsteroidal anti-inflammatory drugs (NAIDS), and even the disruptive development of biological therapies against diverse cytokines. Several of these outstanding achievements have in common that they were initially developed to cope with the inflammation associated with musculoskeletal pathologies such as acetylsalicylic acid, ibuprofen, corticoids, and anti-TNFs. It is now clear that this set of diseases has been a driving force for impulse scientific research on inflammation management. Nonetheless, too much work remains to be done to achieve full control of the inflammation and its consequences. Therefore, once again, we are going to use the huge specific weight of inflammation in musculoskeletal pathologies to achieve further insight into the physiology and pathophysiology of this essential process.
Thus, this Special Issue entitled “Inflammation and the Musculoskeletal System” will publish reviews and experimental findings on novel advances in molecular science that expand our knowledge on inflammation and its pharmacological control in any tissue or cell type of the musculoskeletal system. Likewise, clinical submissions with biomolecular experiments are also welcomed.
Dr. Rodolfo Gõmez
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- rheumatoid arthritis
- innate immunity
- rheumatic diseases